About David Ramsay
David Ramsay is a director at Savara.
Form D filings name David Ramsay as a director at EXUMA Biotech.
David Ramsay reports to the SEC as a director or officer of 3 public companies, including Halozyme Therapeutics (HALO) and LA Jolla Pharmaceutical (LJPC).
David Ramsay first appears on SEC filings in 2007.
Experience
This experience comes from David Ramsay's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Ramsay in the role, so the role may have started earlier or lasted longer.
EB
EXUMA Biotechnology Current
Board of Directors
2017 – Present
SI
Savara Inc Current
Board of Directors
2011 – Present · Public company (SVRA)
HI
Halozyme Therapeutics, Inc. Current
EVP, President, Drug Delivery
Chief Financial Officer (2003 – 2015)
2003 – Present · Public company (HALO)
EXUMA Biotech Corp.
Director
2017 – 2026 · West Palm Beach, FL
Develops cell and gene therapies for people with cancer and autoimmune diseases.
LC
LA Jolla Pharmaceutical Co.
Board of Directors
2019 – 2022 · Public company (LJPC)
BI
Bonti, Inc.
Chief Financial Officer
2018
Key Colleagues at Startups
The people David Ramsay works with at each company, as listed on that company's latest Form D.
EXUMA Biotech Corp. · Form D, Aug 20, 2026
Gregory Frost
Chairman & Chief Executive Officer
Frank McCormick
Director
Richard Yan
Vice President of Finance & Controller
Daniel Flynn
Director
Houston Holmes
Director